We are live on ! Find out more
TXMD icon

TherapeuticsMD
TXMD

39 hedge funds and large institutions have $7.61M invested in TherapeuticsMD in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

77% more call options, than puts

Call options by funds: $92K | Put options by funds: $52K

8% more funds holding

Funds holding: 36 → 39 (+3)

3.74% more ownership

Funds ownership: 28.24% → 31.98% (+3.7%)

16% less capital invested

Capital invested by funds: $9.02M → $7.61M (-$1.41M)

55% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 11

Holders
39
Holders Change
+3
Holders Change %
+8.33%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
11
Closed
3
Calls
$92K
Puts
$52K
Net Calls
+$40K
Net Calls Change
-$193K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$315K
2
TC
Tejara Capital
United Kingdom
+$78K
3
CC
Clearline Capital
New York
+$26.1K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$5.63K
5
UBS Group
UBS Group
Switzerland
+$1.39K

Top Sellers

Rank Fund Capital Flow
1
SMH
Sanders Morris Harris
Texas
-$75.5K
2
SFI
Susquehanna Fundamental Investments
Pennsylvania
-$47.2K
3
Bank of America
Bank of America
North Carolina
-$19.5K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$6.13K
5
GF
Gabelli Funds
New York
-$4.83K
Name Holding Trade Value Shares
Change 		Change in
Stake
PS
26
Principal Securities
Iowa
$284 +$304 +126 New
HNB
27
Huntington National Bank
Ohio
$270 – – –
Barclays
28
Barclays
United Kingdom
$142 +$152 +63 New
Osaic Holdings
29
Osaic Holdings
Arizona
$81 -$519 -215 -86%
PWA
30
Provenance Wealth Advisors
Florida
$45 – – –
FWM
31
Focused Wealth Management
New York
$36 – – –
TRCT
32
Tower Research Capital (TRC)
New York
$25 -$2.24K -928 -99%
B
33
Birchbrook
Maine
$23 +$24 +10 New
HI
34
Harbour Investments
Wisconsin
$18 – – –
GWMI
35
Guardian Wealth Management (Illinois)
Illinois
$5 – – –
Qube Research & Technologies (QRT)
36
Qube Research & Technologies (QRT)
United Kingdom
$5 – – –
APC
37
Aspire Private Capital
North Carolina
$2 – – –
SMH
38
Sanders Morris Harris
Texas
– -$75.5K -25,000 Closed
SFI
39
Susquehanna Fundamental Investments
Pennsylvania
– -$47.2K -15,619 Closed
Royal Bank of Canada
40
Royal Bank of Canada
Ontario, Canada
– -$6.13K -2,540 -94%
Legacy Financial Group (Iowa)
41
Legacy Financial Group (Iowa)
Iowa
– -$302 -100 Closed
HGERS
42
Householder Group Estate & Retirement Specialist
Arizona
– +$72 +30 New
1
2

TXMD Hedge Fund Activity: Q4 2023 in Review

39 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q4 2023, worth a combined $7.61M — down 16% from $9.02M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new TXMD positions and 3 closed out — a net gain of 3 holders — while 5 added to existing stakes and 11 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $315K. The largest seller was Sanders Morris Harris, exiting entirely with an estimated $75.5K sold.

  • 39 institutional investors held TherapeuticsMD (TXMD) as of Q4 2023, up from 36 in Q3 2023.
  • Funds reported $7.61M of TherapeuticsMD stock for Q4 2023, down 16% quarter-over-quarter.
  • 6 funds opened new TherapeuticsMD positions in Q4 2023 and 3 closed out, a net change of +3 holders.
  • The largest TherapeuticsMD buyer in Q4 2023 was Morgan Stanley, an estimated $315K added.
  • The largest TherapeuticsMD seller in Q4 2023 was Sanders Morris Harris, an estimated $75.5K sold.

Based on aggregated 13F filings for Q4 2023.